San Francisco, 7
September 2018: The global critical
care diagnostics market is
expected to reach USD 1.29 billion by 2024, according to a new report by Grand
View Research, Inc. The critical care diagnostics market is expected to grow at
a lucrative rate in the next few years. The key factors supporting the
industry’s growth comprise the rapid awareness and acknowledgment of these
tests by physicians and patients, the rise in geriatric population and chronic
health conditions, the employment of telehealth services in remote areas, and
technological advancements. The increased cost of the molecular diagnostics and
dearth of skilled labor are factors that are expected to hinder the growth of
the industry.
The critical care diagnostics market by
test type is categorized into routine and special chemistry, flow cytometry,
hematology, immunoproteins, microbial and infectious diseases, coagulation
testing, and others. The microbial and infectious diseases test diagnostics
segment is projected to grow at the highest rate with a CAGR of over 5% during
the forecast period. For example, healthcare systems spend a substantial amount
of resources in the collection and processing of blood cultures for the
identification of pathogens.
Critical care diagnostic tests, such as the
nucleic acid amplification test, allow clinicians to detect and identify
organisms more rapidly and accurately and provide guidance to clinicians, who
aspire to commence the appropriate antimicrobial therapy as fast as possible
and terminate the use of avoidable drugs. The critical care diagnostic market
by the end-user is categorized into operation rooms, emergency rooms, and
ICU’s. The emergency rooms segment in the industry is anticipated to witness
the highest growth rate during the forecast period.
Access
Research Report of Critical Care
Diagnostics Market@: www.grandviewresearch.com/industry-analysis/critical-care-diagnostics-market
Further key findings from the study suggest:
· The Asia Pacific region is estimated to
dominate the critical care market in terms of the highest growth rate, with a
CAGR of around 9.1% during the forecast period. The large presence of geriatric
population, increasing prevalence of chronic diseases, increase in the number
of specialty hospitals in the Asia Pacific region, and improving healthcare
services and infrastructures in rural areas are the factors fueling the market
growth.
· The immunoproteins diagnostic test segment
is estimated to account for the largest share of the critical care diagnostic
market by type. The rise in demand for rapid and accurate preventive healthcare
services is one of the major factors driving this market growth.
· On the basis of end-users, approximately
20% of acute-care patients get admitted into ICU’s, whereas nearly 58% get
admitted into emergency rooms. The emergency rooms are expected to witness
exponential growth with the highest CAGR during the forecast period. The recent
rise in the patient demand for ER services is due to its ability to provide
initial acute care diagnosis and treatment of critically ill patients.
· Some major players in this industry include
Abbott., Alere, Inc., Beckman-Coulter, Roche Diagnostics, and Becton Dickinson
& Co., among others.
Browse more reports of this category by Grand View
Research at: www.grandviewresearch.com/industry/clinical-diagnostics
Grand View Research has segmented the
global critical care diagnostics market on the basis of test type, end-user,
and region:
Global Critical Care Diagnostics Type
Outlook (Revenue, USD Million, 2013 - 2024)
·
Routine and special chemistry
·
Flow cytometry
·
Hematology
·
Immunoproteins
·
Microbial and infectious diseases
·
Coagulation test
·
Others
Global Critical Care Diagnostics End-user
Outlook (Revenue, USD Million, 2013 - 2024)
·
Operating rooms
·
Emergency rooms
·
Intensive care units
·
Others
Critical Care Diagnostics Regional Outlook (Revenue,
USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
China
o
India
·
Latin America
o
Mexico
o
Brazil
·
Middle East and Africa
o
South Africa
o
Saudi Arabia
Access Press Release of
Critical Care Diagnostics Market@: www.grandviewresearch.com/press-release/global-critical-care-diagnostics-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research
reports, customized research reports, and consulting services. To help
clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment